Prof. Jonathan Javitt, MD, MPH, CEO of Nrx Pharmaceuticals, is an adjunct professor of Johns Hopkins University and former White House healthcare advisor.
These patients have previously been excluded from clinical trials of nearly all currently marketed antidepressants. We aspire to change that reality for more than 150,000 Americans each year who present for emergency care and more than 25,000 each year... https://t.co/HUiDJVgBqx